Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02862080 · ClinicalTrials.gov registry record · NA
Combining tsDCS and Exoskeleton Gait Training on Spinal Excitability in SCI
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02862080 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 4 participants.
The verdict
NCT02862080, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of the study is to determine whether transcutaneous spinal direct current stimulation (tsDCS) is safe for individuals with spinal cord injury (SCI). tsDCS is an electrical current applied to the skin. The plan is to also study the potential neurophysiological changes (changes in speed and excitability of the nerves) and functional improvements in gait (for example, gait quality, speed and walking distance) for individuals with SCI after combined application of tsDCS and exoskeleton assisted gait training.
Interventions
- DEVICE Ekso
- DEVICE cathode tsDCS
- DEVICE anode tsDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-02-13 |
| Est. Completion | 2017-11-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02862080
The ClinicalTrials.gov registry entry for NCT02862080 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ekso is the first listed.
NCT02862080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02862080 about?
NCT02862080 is a clinical study titled "Combining tsDCS and Exoskeleton Gait Training on Spinal Excitability in SCI". The purpose of the study is to determine whether transcutaneous spinal direct current stimulation (tsDCS) is safe for individuals with spinal cord injury (SCI). tsDCS is an electrical current applied to the skin. The plan is to also study the potential neurophysiological changes (changes in speed an...
What is the current status of trial NCT02862080?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2017-02-13. Estimated completion is 2017-11-17.
What interventions are being tested in trial NCT02862080?
The interventions under investigation include: Ekso (DEVICE), cathode tsDCS (DEVICE), anode tsDCS (DEVICE).
Who is sponsoring clinical trial NCT02862080?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.